U. Gonzalez, M. Pinart, M. Rengifo-pardo, A. Macaya, and J. Alvar, Interventions for American cutaneous and mucocutaneous leishmaniasis, p.4834, 2009.
DOI : 10.4269/ajtmh.1997.57.309

U. Gonzalez, M. Pinart, L. Reveiz, and J. Alvar, Interventions for Old World cutaneous leishmaniasis, Cochrane Database Syst Rev, vol.275, issue.5, p.5067, 2008.
DOI : 10.1007/BF00417211

U. Gonzalez, M. Pinart, L. Reveiz, M. Rengifo-pardo, and J. Tweed, Designing and Reporting Clinical Trials on Treatments for Cutaneous Leishmaniasis, Clinical Infectious Diseases, vol.51, issue.4, pp.409-419, 2010.
DOI : 10.1086/655134

T. Lang, P. Cheah, T. Hien, and R. Chilengi, Collaborators in Global Health Clinical Trials.org (2009) Global Health Clinical Trials Programme Available: http://globalhealthtrials, 2013.

S. The and . Project, Trial Protocol tool Available http://globalhealthtrials.tghn.org/site_media/media, Supporting Policy relevant Reviews and Trials)TrialProtocolTool.html Accessed, vol.29, 2001.

R. Saenz, H. Paz, and J. Berman, Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis, The American Journal of Medicine, vol.89, issue.2, pp.147-155, 1990.
DOI : 10.1016/0002-9343(90)90292-L

I. Velez, S. Agudelo, E. Hendrickx, J. Puerta, and M. Grogl, Inefficacy of Allopurinol as Monotherapy for Colombian Cutaneous Leishmaniasis, Annals of Internal Medicine, vol.126, issue.3, pp.232-236, 1997.
DOI : 10.7326/0003-4819-126-3-199702010-00010

B. Herwaldt, B. Arana, and T. Navin, The Natural History of Cutaneous Leishmaniasis in Guatemala, Journal of Infectious Diseases, vol.165, issue.3, pp.518-527, 1992.
DOI : 10.1093/infdis/165.3.518

B. Arana, C. Mendoza, N. Rizzo, and A. Kroeger, Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala., The American Journal of Tropical Medicine and Hygiene, vol.65, issue.5, 2001.
DOI : 10.4269/ajtmh.2001.65.466

T. Navin, B. Arana, F. Arana, A. De-merida, and A. Castillo, Placebo-Controlled Clinical Trial of Meglumine Antimonate (Glucantime) Vs. Localized Controlled Heat in the Treatment of Cutaneous Leishmaniasis in Guatemala, The American Journal of Tropical Medicine and Hygiene, vol.42, issue.1, pp.43-50, 1990.
DOI : 10.4269/ajtmh.1990.42.43

R. Guderian, M. Chico, M. Rogers, K. Pattishall, and M. Grogl, Placebo Controlled Treatment of Ecuadorian Cutaneous Leishmaniasis, The American Journal of Tropical Medicine and Hygiene, vol.45, issue.1, pp.92-97, 1991.
DOI : 10.4269/ajtmh.1991.45.92

R. Palacios, L. Osorio, L. Grajalew, and M. Ochoa, Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species., The American Journal of Tropical Medicine and Hygiene, vol.64, issue.3, 2001.
DOI : 10.4269/ajtmh.2001.64.187

A. Cruz, P. Rainey, B. Herwaldt, G. Stagni, and R. Palacios, Pharmacokinetics of Antimony in Children Treated for Leishmaniasis with Meglumine Antimoniate, The Journal of Infectious Diseases, vol.195, issue.4, pp.602-608, 2007.
DOI : 10.1086/510860

A. Fernandez-olmos, Y. Diaz, C. Ovalle, S. Muvdi, and L. Valderrama, Drug susceptibility of Leishmania vianna species in Colombia, 2011.

G. Harms, A. Chehade, M. Douba, M. Roepke, and A. Mouakeh, A randomized trial comparing a pentavalent antimonial drug and recombinant interferon-?? in the local treatment of cutaneous leishmaniasis, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.85, issue.2, pp.214-216, 1991.
DOI : 10.1016/0035-9203(91)90026-U

V. Amato, F. Tuon, H. De-andrade, J. Bacha, H. Pagliari et al., Immunohistochemistry and polymerase chain reaction on paraffin-embedded material improve the diagnosis of cutaneous leishmaniasis in the Amazon region, International Journal of Dermatology, vol.41, issue.10, pp.1091-1095, 2009.
DOI : 10.1590/S0074-02762005000200013

A. Boggild, A. Ramos, D. Espinosa, B. Valencia, and N. Veland, Clinical and Demographic Stratification of Test Performance: A Pooled Analysis of Five Laboratory Diagnostic Methods for American Cutaneous Leishmaniasis, The American Journal of Tropical Medicine and Hygiene, vol.83, issue.2, 2010.
DOI : 10.4269/ajtmh.2010.09-0414

B. Pourmohammadi, M. Motazedian, G. Hatam, M. Kalantari, and P. Habibi, Comparison of three methods for diagnosis of cutaneous leishmaniasis, Iran J Parasitol, vol.5, pp.1-8, 2010.

F. Shahbazi, S. Shahabi, B. Kazemi, M. Mohebali, and A. Abadi, Evaluation of PCR assay in diagnosis and identification of cutaneous leishmaniasis: a comparison with the parasitological methods, Parasitology Research, vol.24, issue.5, pp.1159-1162, 2008.
DOI : 10.1093/clind/24.4.684

J. Arevalo, L. Ramirez, V. Adaui, M. Zimic, and G. Tulliano, Species on the Response to Antimonial Treatment in Patients with American Tegumentary Leishmaniasis, The Journal of Infectious Diseases, vol.195, issue.12, pp.1846-1851, 2007.
DOI : 10.1086/518041

R. Rojas, L. Valderrama, M. Valderrama, M. Varona, and M. Ouellette, Infection, The Journal of Infectious Diseases, vol.193, issue.10, pp.1375-1383, 2006.
DOI : 10.1086/503371
URL : https://hal.archives-ouvertes.fr/hal-00866399

J. Soto, B. Arana, J. Toledo, N. Rizzo, and J. Vega, Miltefosine for New World Cutaneous Leishmaniasis, Clinical Infectious Diseases, vol.38, issue.9, pp.1266-1272, 2004.
DOI : 10.1086/383321

J. Ewing, Detecting alcoholism. The CAGE questionnaire, JAMA: The Journal of the American Medical Association, vol.252, issue.14, pp.1905-1907, 1984.
DOI : 10.1001/jama.252.14.1905

C. Oster, J. Chulay, L. Hendricks, C. Pamplin, and W. Ballou, American Cutaneous Leishmaniasis: a Comparison of Three Sodium Stibogluconate Treatment Schedules *, The American Journal of Tropical Medicine and Hygiene, vol.34, issue.5, pp.856-860, 1985.
DOI : 10.4269/ajtmh.1985.34.856

W. Ballou, J. Mcclain, D. Gordon, G. Shanks, and J. Andujar, SAFETY AND EFFICACY OF HIGH-DOSE SODIUM STIBOGLUCONATE THERAPY OF AMERICAN CUTANEOUS LEISHMANIASIS, The Lancet, vol.330, issue.8549, pp.13-16, 1987.
DOI : 10.1016/S0140-6736(87)93053-4

B. Salah, A. Buffet, P. Morizot, G. , B. Massoud et al., WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study, PLoS Neglected Tropical Diseases, vol.13, issue.5, p.432, 2009.
DOI : 10.1371/journal.pntd.0000432.s002
URL : https://hal.archives-ouvertes.fr/pasteur-00859427

T. Navin, B. Arana, F. Arana, J. Berman, and J. Chajon, Placebo-Controlled Clinical Trial of Sodium Stibogluconate (Pentostam) versus Ketoconazole for Treating Cutaneous Leishmaniasis in Guatemala, Journal of Infectious Diseases, vol.165, issue.3, pp.528-534, 1992.
DOI : 10.1093/infdis/165.3.528

D. Food and . Administration, Reporting Serious Problems to FDA: What is a Serious Adverse Event? Available http://www.fda.gov/safety/ medwatch, 2011.

S. Senn, The misunderstood placebo, pp.40-46, 2001.

S. Chow and J. Liu, Hypotheses testing and p-values. In: Design and analysis of clinical trials Concept and methodologies, pp.72-73, 2004.

D. Agostino, R. Sr, J. Massaro, and L. Sullivan, Non-inferiority trials: design concepts and issues -the encounters of academic consultants in statistics, pp.169-186, 2003.

S. Sundar, M. Rai, J. Chakravarty, D. Agarwal, and N. Agrawal, New Treatment Approach in Indian Visceral Leishmaniasis: Single???Dose Liposomal Amphotericin B Followed by Short???Course Oral Miltefosine, Clinical Infectious Diseases, vol.47, issue.8, pp.1000-1006, 2008.
DOI : 10.1086/591972

S. Sundar, P. Sinha, M. Rai, D. Verma, and K. Nawin, Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial, The Lancet, vol.377, issue.9764, pp.477-486, 2011.
DOI : 10.1016/S0140-6736(10)62050-8

E. Soliman, The ethics of non-inferiority trials, The Lancet, vol.371, issue.9616, pp.895-896, 2008.
DOI : 10.1016/S0140-6736(08)60406-7

M. Rothmann, N. Li, G. Chen, G. Chi, and R. Temple, Design and analysis of non-inferiority mortality trials in oncology, Statistics in Medicine, vol.7, issue.2, pp.239-264, 2003.
DOI : 10.1177/009286150103500212

V. Hasselblad and D. Kong, Statistical Methods for Comparison to Placebo in Active-Control Trials, Drug Information Journal, vol.11, issue.2, pp.435-449, 2001.
DOI : 10.1002/sim.4780110807

I. Abraha and A. Montedori, Modified intention to treat reporting in randomised controlled trials: systematic review, BMJ, vol.340, issue.jun14 1, p.2697, 2010.
DOI : 10.1136/bmj.c2697

A. Garrett, Therapeutic equivalence: fallacies and falsification, Statistics in Medicine, vol.14, issue.5, pp.741-762, 2003.
DOI : 10.2307/1403444

S. Senn, Consensus and Controversy in Pharmaceutical Statistics, Journal of the Royal Statistical Society: Series D (The Statistician), vol.49, issue.2, pp.135-176, 2000.
DOI : 10.1111/1467-9884.00227

B. Jones, P. Jarvis, J. Lewis, and A. Ebbutt, Trials to assess equivalence: the importance of rigorous methods, BMJ, vol.313, issue.7048, pp.36-39, 1996.
DOI : 10.1136/bmj.313.7048.36

E. Brittain and D. Lin, A comparison of intent-to-treat and per-protocol results in antibiotic non-inferiority trials, Statistics in Medicine, vol.17, issue.1, pp.1-10, 2005.
DOI : 10.1002/sim.1934

G. Piaggio, D. Elbourne, D. Altman, S. Pocock, and S. Evans, Reporting of Noninferiority and Equivalence Randomized Trials, JAMA, vol.295, issue.10, pp.1152-1160, 2006.
DOI : 10.1001/jama.295.10.1152

P. Gotzsche, Noninferiority and equivalence randomized trials: lessons and reservations?secondary publication], Ugeskr Laeger, vol.168, pp.3137-3139, 2006.

D. Sheng and M. Kim, The effects of non-compliance on intent-to-treat analysis of equivalence trials, Statistics in Medicine, vol.19, issue.7, pp.1183-1199, 2006.
DOI : 10.1038/bjc.1993.402

M. Sanchez, M. Chen, and X. , Choosing the analysis population in noninferiority studies: per protocol or intent-to-treat, pp.1169-1181, 2006.

R. Newcombe and E. Stein, Confidence intervals for a binomial proportion, Statistics in Medicine, vol.78, issue.12, pp.1283-1285, 1995.
DOI : 10.1002/sim.4780131209

J. Whitehead and I. Stratton, Group Sequential Clinical Trials with Triangular Continuation Regions, Biometrics, vol.39, issue.1, pp.227-236, 1983.
DOI : 10.2307/2530822

B. Salah, A. Zakraoui, H. Zaatour, A. Ftaiti, A. Zaafouri et al., A Randomized, Placebo-Controlled Trial in Tunisia Treating Cutaneous Leishmaniasis with Paromomycin Ointment, The American Journal of Tropical Medicine and Hygiene, vol.53, issue.2, pp.162-166, 1995.
DOI : 10.4269/ajtmh.1995.53.162

E. Kaplan and P. Meier, Nonparametric Estimation from Incomplete Observations, Journal of the American Statistical Association, vol.37, issue.282, pp.457-481, 1958.
DOI : 10.1214/aoms/1177731566

M. Bauer and M. Kieser, A unifying approach for confidence intervals and testing of equivalence and difference, Biometrika, vol.83, issue.4, pp.934-937, 1996.
DOI : 10.1093/biomet/83.4.934

N. White, Editorial: Clinical trials in tropical diseases: a politically incorrect view, Tropical Medicine and International Health, vol.11, issue.10, pp.1483-1484, 2006.
DOI : 10.1111/j.1365-3156.2006.01765.x